Informace o publikaci

SORL1 variant links endosomal amyloid precursor protein mis-sorting to axonal transport defects and neuronal dysfunction

Logo poskytovatele
Logo poskytovatele
Logo poskytovatele
Autoři

LÉP Miriam PLEŠINGROVÁ Klára SEDMÍK Jiří CESNÁRIKOVÁ Soňa FEOLE Monica BERNATÍK Ondřej POZO DEVOTO Victorio Martin HŘÍBKOVÁ Hana AMRUZ ČERNÁ Kateřina FOJTÍK Petr VAŠKOVICOVÁ Naděžda BÁRTOVÁ Simona POSPÍŠILOVÁ Veronika VÁŇOVÁ Tereza ANDERSEN Olav Michael BOHAČIAKOVÁ Dáša RAŠKA Jan

Rok publikování 2026
Druh Recenzovaný odborný článek
Časopis / Zdroj ALZHEIMERS & DEMENTIA
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.71782
Doi https://doi.org/10.1002/alz.71782
Klíčová slova Alzheimer's disease; axonal transport; endosomal trafficking; iPSCs; neuronal electrophysiology; SORL1
Popis INTRODUCTION SORL1 encodes the sorting receptor SORLA, a major genetic contributor to Alzheimer's disease (AD). Although SORL1 loss disrupts endosomal trafficking and promotes amyloidogenic amyloid precursor protein (APP) processing, the functional consequences of specific missense variants in human neurons remain unclear. METHODS We used isogenic induced pluripotent stem cell (iPSC)-derived NGN2 neurons and 3D cerebral organoids carrying wild-type, SORL1 p.Y1816C knock-in, or SORL1 knockout alleles. We analyzed SORLA maturation and shedding, APP localization, amyloid-beta (A beta) secretion, endosomal morphology, axonal transport of Rab5+ endosomes and APP, and network activity. RESULTS The p.Y1816C variant impaired SORLA maturation and shedding and, together with knockout, caused enlarged early endosomes, APP retention, elevated A beta secretion, amyloid deposition in organoids, axonal swellings, disrupted axonal transport, and neuronal hyperexcitability. CONCLUSIONS The SORL1 p.Y1816C variant is pathogenic in human neurons, and we reveal novel roles for SORLA in axonal transport and neuronal excitability. These findings highlight endosomal trafficking disruption as a central mechanism in AD pathogenesis.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info